Gene Query: BIN3

Dataset Description Geneva Score
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 39.41
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 29.92
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 24.57
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 21.18
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 17.85
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 16.43
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 16.34
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 14.83
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 14.67
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 14.67
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 13.0
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 12.34
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 11.09
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 10.87
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 10.8
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 10.8
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 10.65
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 10.38
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 9.91
Identification of transcription start sites for human A549 cell line using ReCappable-seq 9.75
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 9.23
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 9.19
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 8.48
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 8.48
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 8.4
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 8.37
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 8.06
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 7.74
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 7.74
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 7.69
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 6.86
The regulartory role of ZCCHC24 in splicing machinery 6.6
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 6.21
Cell responses to dysregulated VZV-induced cell-cell fusion 5.88
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 5.74
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 5.7
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 5.7
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 5.69
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 5.58
Intron retention induced by microsatellite expansions as a disease biomarker. 5.47
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 5.41
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 5.38
Human neutrophil genome during PMA- and E. coli encounter-induced activation 5.38
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 5.29
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 5.23
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 5.23
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 5.2
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 5.19
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.11
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 5.1
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 5.1
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 5.07
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 5.04
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 4.9
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 4.72
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 4.71
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 4.65
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 4.65
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 4.63
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.62
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 4.57
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 4.56
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 4.44
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 4.35
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 4.35
RNA-seq of IL-4 stimulated human keratinocytes 4.34
A transcriptome-wide divergence in protein translation scales with LIN28B expression 4.3
RNA-seq melanoma 4.29
Irf9 function in immunity in mouse 4.27
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 4.27
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 4.23
The evolution of N6-methyladenosine in primates 4.23
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 4.03
Differential gene expression of human melanoma cells [RNA-seq] 4.03
RNAseq Analysis in glioblastoma cells treated with Mepazine 3.99
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 3.86
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.82
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 3.8
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.73
Transcriptional responses of melanoma cells to BRAF inhibition 3.65
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 3.63
Primary human trophoblast from term placenta 3.61
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 3.6
Proteomics identifies a marker signature of MAPKi resistance in melanoma 3.57
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.55
Comprehensive comparative analysis of 5’ end RNA sequencing methods 3.41
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 3.41
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 3.37
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 3.25
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 3.24
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 3.24
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.24
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.23
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.21
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 3.2
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 3.05
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 3.02
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.99
Transcriptome of diurnal human blood neutrophils 2.96
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.96
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 2.93
Patient-derived xenograft platform for metastatic melanoma 2.9
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 2.8
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 2.78
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 2.7
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.65
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 2.59
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 2.58
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.56
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 2.56
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 2.48
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 2.48
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.45
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 2.44
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.44
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.44
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 2.44
Gene expression changes in human melanoma cell lines compared to primary melanocytes 2.44
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 2.42
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 2.4
RNA-Seq and expression data from human adipose tissue 2.4
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.4
RNA-seq analysis upon ARID1B overexpression 2.37
Total RNA sequencing of WT intestinal orgaonids. 2.35
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 2.34
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.34
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 2.33
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 2.33
Human Treg NaCl stimulation 2.3
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 2.29
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 2.25
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 2.24
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 2.23
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 2.22
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 2.2
Oncogenic roles of ARID5B in T-ALL 2.17
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 2.17
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 2.16
TOP2B disturbed the quality of human oocytes with advanced maternal age 2.14
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 2.14
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 2.12
mRNA expression profile of Lymphocytes 2.09
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 2.08
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 2.08
An optimization system for isolating and sequencing of single human colon cancer cells 2.07
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 2.01
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 2.01
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 2.01
R430: A potent inbibitor of DNA and RNA viruses 1.95
The effect of PPARG inhibition on human angiomyolipoma cells 1.91
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 1.9
RNA-seq in transgenic cells 1.89
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 1.89
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 1.88
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 1.86
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 1.86
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 1.85
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 1.84
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 1.82
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 1.82
CROP-Seq in Primary Human T Cells 1.82
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 1.81
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 1.81
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 1.81
MARCKS and lnc-MARCKS act as inflammation regulators 1.79
Transcriptome analysis of BAP1 knockout and restoration 1.78
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 1.78
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 1.78
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.77
Dermal endothelial cells of type 2 diabetic patients 1.76
An acquired vulnerability of drug resistant melanoma with therapeutic potential 1.76
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 1.76
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 1.74
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 1.74
Stem and effector CD8 T-cells from human cancers 1.73
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 1.72
Gene expression signatures of innate lymphoid cells from human blood 1.7
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.64
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 1.64
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 1.62
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 1.62
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.62
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 1.62
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 1.61
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.61
Single-cell analysis of adult human ovary using 10X genomics 1.61
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 1.6
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 1.6
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 1.6
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 1.59
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 1.57
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 1.57
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 1.56
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 1.56
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 1.55
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 1.54
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.54
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 1.53
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 1.53
RNA-seq of tumor cells following angiopellosis extravasation 1.52
Impact of dieldrin on transcription in Jurkat T cells 1.51
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.51
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.51
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 1.5
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 1.49
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 1.49
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 1.49
Transcriptome analysis of CNS leukemia 1.49
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 1.49
HNF1 regulates critical functions of the human epididymis epithelium. 1.49
RNA-sequencing of human tendon after injury 1.48
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 1.48
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 1.48
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 1.45
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.45
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 1.45
DRB/GRO-Seq -/+ UV 1.45
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.45
Primary Human B-cell Temporal Response to CD40L Stimulation 1.45
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 1.44
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 1.44
Genome-wide chromatin analysis of Ewing sarcoma 1.44
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.43
DART-seq: an antibody-free method for global m6A detection 1.42
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.41
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.41
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 1.4
Direct Isolation and Characterization of Human Nephron Progenitors. 1.39
Transcriptional dependencies in diffuse intrinsic pontine glioma 1.39
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.39
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 1.38
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.34
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.34
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.34
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 1.34
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 1.33
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 1.33
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.32
Selective suppression of endothelial cytokine production by progesterone receptor 1.31
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 1.31
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 1.3
Role of COP1 on MAP kinase transcriptional output in melanoma 1.3
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.3
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 1.28
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 1.27
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 1.27
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 1.27
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 1.27
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.26
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 1.26
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.25
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 1.25
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.23
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 1.23
PTHrP overexpression in MCF7 cells 1.22
Intrahepatic MAIT cell gene expression revealed by RNA-seq 1.22
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 1.22
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 1.21
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.21
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.21
Investigate A2M treatment on human prostate cancer xenograft in mice 1.2
Investigate A2M treatment on human prostate cancer and mouse liver 1.2
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 1.19
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 1.19
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 1.18
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 1.17
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.17
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.16
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 1.16
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.16
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.16
Gene expression activation in CLL mediated by MSCs contact 1.15
KSDM1b Role in Ewing Sarcoma 1.15
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.14
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.14
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 1.13
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.13
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 1.13
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.12
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 1.1
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.09
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.09
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 1.09
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.08
RNA-Seq from human ILC transitional populations 1.08
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.08
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 1.08
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 1.08
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.05
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.05
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 1.04
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.03
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 1.0
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.0
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.99
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.99
U2AF1 mutations alter splice site recognition in hematological malignancies 0.98
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.98
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 0.97
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 0.97
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.97
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.95
RNA-seq of shEZH2 cells 0.95
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.95
Glioblastoma stem cells infected by ZIKA virus 0.94
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.93
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.92
Epigenetic reprogramming of melanoma cells by vitamin C treatment 0.91
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.91
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.9
4sU-seq of HFF exposed to salt and heat stress 0.9
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 0.89
Transcriptomes of oxLDL exposed trained monocytes 0.89
oxLDL exposed trained monocytes 0.89
Single-Cell Genotyping of Transcriptomes 0.88
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.88
Characterization of human ILC2 subsets 0.87
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.87
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 0.87
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.87
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.86
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 0.86
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 0.85
UV_24h_GRO-Seq 0.85
X-Ray induced DNA-Hydroxymethylation changes 0.85
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 0.84
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.84
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 0.84
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.84
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 0.84
SNHG5 siRNA knock down in HCT116 cells 0.83
Gene expression profile in breast cancer cell lines using RNA sequencing 0.81
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 0.81
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.8
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 0.8
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 0.79
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 0.79
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.76
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 0.76
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 0.76
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.76
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.75
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.75
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.75
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 0.74
mRNA expression profile of Lymphocytes by high-throuput sequencing 0.73
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.71
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.71
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 0.71
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 0.7
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.7
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 0.7
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 0.69
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 0.69
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.67
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.66
Dysregulated immune system networks in war veterans with PTSD 0.65
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.65
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.64
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.63
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.63
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.63
Genome-wide discovery of human splicing branchpoints [RNAse] 0.61
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.61
Human Treg IL-12 stimulation 0.61
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.6
Global gene expression profile of dasatinib-resistant RCH-ACV cells 0.59
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 0.58
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.57
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 0.56
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 0.56
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.56
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.56
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.56
RNA sequencing of T-ALL (COG study) 0.55
Analyses of T-ALL (COG study) 0.55
Differential gene expression in Jagged1 treated human dental pulp cells. 0.55
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 0.54
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.54
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.54
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.53
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 0.52
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.51
Effect of drugs on transcriptomic profiles 0.51
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.51
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 0.5
quanTIseq: quantifying immune contexture of human tumors 0.5
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.49
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.49
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.49
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.48
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.48
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.47
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 0.47
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.43
Widespread intronic polyadenylation diversifies immune cell transcriptomes 0.43
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.42
Functional significance of the HIV-1 Tat signature amino acid residues 0.42
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.41
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.41
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.41
0.41
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.41
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.4
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.4
Transcriptional effect of ETV1 knockdown in melanoma cells 0.39
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.38
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.38
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.38
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.37
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.37
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.37
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.36
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.36
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.35
The DNA methylation landscape of human melanoma 0.34
The DNA methylation landscape of human melanoma [RNA-Seq] 0.34
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.34
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 0.34
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.34
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.33
Targeted enhancer activation by a subunit of the integrator complex 0.32
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.31
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 0.29
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 0.29
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.29
circRNA-sequencing 0.29
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.29
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 0.29
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.28
RNA-sequencing of healthy human skeletal myocytes 0.28
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.28
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.28
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.26
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.25
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.24
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.24
miRNAs affected by antagomiR-17 treatment 0.22
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.21
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.21
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.21
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.21
naive T cell heterogeneity after neonatal thymectomy 0.21
Leucegene: AML sequencing (part 6) 0.2
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.2
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 0.2
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.2
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.19
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.19
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 0.18
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.18
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.18
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.17
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 0.17
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.17
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.16
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.15
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 0.15
Tpl-2 small molecule project 0.15
Tpl-2 and MEK small molecule inhibitors 0.15
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.14
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.14
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.14
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.14
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.13
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.13
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.12
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.12
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.12
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.11
High-resolution comparative analysis of great ape genomes 0.1
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.1
Expression analysis of the TAF1 syndrome 0.1
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.1
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.1
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.09
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.08
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.08
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.08
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.08
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.07
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.07
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.07
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.07
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.06
RNA-seq of primary patient AML samples 0.05
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.05
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.05
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.04
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.04
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.04
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.03
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.03
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.03
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.02
Discovering human diabetes-risk gene function with genetics and physiological assays 0.02
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.02
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 0.02
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.01
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation